ART3 Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-00144APC
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunohistochemistry-Paraffin
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ART3 Antibody [Allophycocyanin]
Immunogen
Produced in rabbits immunized with purified, recombinant Human ART3 (Accession#: AAH08397.1; Met1-Ser362).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ART3 Antibody [Allophycocyanin]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ART3
Alternate Names
ADP-ribosyltransferase 3, EC 2.4.2.31, ecto-ADP-ribosyltransferase 3, FLJ26404, Mono(ADP-ribosyl)transferase 3, mono-ADP-ribosyltransferase, NAD(P)(+)--arginine ADP-ribosyltransferase 3, TMART
Gene Symbol
ART3
Additional ART3 Products
Product Documents for ART3 Antibody [Allophycocyanin]
Product Specific Notices for ART3 Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...